PW01-78 - Pharmacoeconomic aspects of dementia therapy

Abstract

ObjectiveWe hypothesized that patients with Alzheimer's disease (AD) not treated with anti-dementia therapy are institutionalized at the earlier AD stages compared to the ones who took nosotropic therapy timely.Methods100 outpatients with AD were treated with AChE-inhibitors in the Moscow Alzheimer's center. The controls were AD patients, hospitalized in gerontopsychiatric units of the Moscow Psychiatric Hospital №15 and not treated with anti-dementia drugs before.ResultsThe mean duration of dementia syndrome in the main group was 73.2±27.6 months compared to 21.6±13.2 months in the control group. The mean duration of the hospitalization in the control group proved to be 6.3±5.6 months (i.e. 29% of dementia syndrome duration). We suggest, that without the antidementia therapy patients of the main group could be hospitalized also for 29% of the duration of dementia syndrome (≥ 21.2 months). The cost of one bed day in Moscow hospitals in 2009 year is 31.2 EUR, thus total expenses for a hospital treatment of one patient with AD for 21.2 months would be 19902.6 EUR (given). The expenses for a treatment of one patient in out-patient clinic for 21.2 months excluding medical staff salary range from 1605.3 EUR (memantine) to 2422 EUR (AChE-inhibitors). Therefore, treatment of AD patients in outpatient clinic instead of hospitalization allows to save 17480.6-18297.3 EUR for public health service budget for each patient.ConclusionLong-term anti-Alzheimer therapy allows to postpone institutionalization. Economic expenses resulted from AD-patients institutionalization more than 8 times exceed the cost of the appropriate therapy in outpatient clinic.